The rush to partner or licence BIT for hep C or HIV since this report has been none. They would have said so if they were negotiating with one or more big pharma. The data has been seen for months. There is no interest imo. Hep B is their last hope imo.
Subsequent Events
No matters or circumstances have arisen since the end of the half-year which significantly affected or may significantly affect the operations of the Company, the results of those operations, or the state of affairs of the Company in future financial years.
Ann: Half Yearly Report and Accounts, page-31
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
